Vera Therapeutics (VERA)
(Delayed Data from NSDQ)
$37.39 USD
-0.23 (-0.61%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $37.41 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VERA 37.39 -0.23(-0.61%)
Will VERA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VERA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VERA
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex
Wall Street Analysts Believe Vera Therapeutics, Inc. (VERA) Could Rally 86.76%: Here's is How to Trade
VERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -34.74% in 4 Weeks, Here's Why You Should You Buy the Dip in Vera Therapeutics, Inc. (VERA)
Down -38.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Vera Therapeutics, Inc. (VERA)
Down -37.74% in 4 Weeks, Here's Why Vera Therapeutics, Inc. (VERA) Looks Ripe for a Turnaround
Other News for VERA
Vera Therapeutics' Atacicept: A Potential Game-Changer In IgA Nephropathy
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Appoints Christy Oliger to Board
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference